Last reviewed · How we verify

Benzedrex (PROPYLHEXEDRINE)

FDA-approved withdrawn Small molecule Quality 24/100

Propylhexedrine, marketed as Benzedrex, is a nasal decongestant currently available in the over-the-counter market. Its key strength lies in its mechanism of action, which effectively stimulates the nasal mucosa to reduce swelling and increase airflow, providing rapid relief for nasal congestion. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic alternatives.

At a glance

Generic namePROPYLHEXEDRINE
Drug classpropylhexedrine
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved
Annual revenue172

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
SEC EDGARRevenue + earnings

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: